EP.TH.41Breast Implant-Associated Anaplastic Large Cell Lymphoma
Author(s) -
Parisa Moori,
Fran Ibison,
Deepa Jacob,
Julie Iddon
Publication year - 2021
Publication title -
british journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.202
H-Index - 201
eISSN - 1365-2168
pISSN - 0007-1323
DOI - 10.1093/bjs/znab309.007
Subject(s) - anaplastic large cell lymphoma , medicine , cd30 , breast implant , anaplastic lymphoma kinase , lymphoma , implant , large cell , oncology , pathology , surgery , cancer , adenocarcinoma , malignant pleural effusion , lung cancer
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare, non-Hodgkin lymphoma which arises within the capsules of breast implants. These particular tumours have expression of CD30 and are negative for Anaplastic Lymphoma Kinase (ALK). Here, we report a case of BIA-ALCL in a 48-year-old woman post breast reconstruction. This case report is aimed at raising awareness and education on the significance of considering the development of BIA-ALCL in cases where cytology is negative and helping better understand this disease process.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom